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ABSTRACT: President Obama has made health reform a top priority for the nation. In addition 
to the initial investments enacted in the American Recovery and Reinvestment Act, the president 
has included a $634 billion health reform reserve fund in his 2010 budget as a downpayment on 
health reform, leaving the legislative details to Congress. Comprehensive reform will likely 
require an investment of $1 trillion or more over the 2010–19 period to achieve coverage for all 
and implement critical system reforms. This report examines policy options that could slow 
growth in health spending, improve health outcomes, and provide additional revenues to finance 
comprehensive reform. It also illustrates how widely estimates of policy options can vary based 
on underlying assumptions. The rich menu of options presented here, along with impact 
estimates, should help policy leaders identify the resources required to make health coverage for 
all and improved health system performance a reality. 
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 EXECUTIVE SUMMARY 
 
 
In February 2009, President Obama sent his first budget to Congress. The budget 
outlined the new Administration’s priorities for health reform: 
• protecting families’ financial health; 
• ensuring that health coverage is affordable; 
• aiming for universality in coverage; 
• providing portability of coverage; 
• guaranteeing consumer choice; 
• investing in prevention and wellness; 
• improving patient safety and the quality of care; and 
• maintaining long-term fiscal sustainability. 
 
Consistent with the president’s belief that health reform should be financially 
sustainable, he included a $634 billion reserve fund to advance reform over the next 
decade, 2010–19. The budget proposal builds on the $150 billion investment included in 
the American Recovery and Reinvestment Act (ARRA, or economic stimulus package) 
enacted in February 2009. 
 
In a departure from the past, the Administration has left the details of the health 
reform legislation to Congress, looking largely to the committees of jurisdiction to 
develop legislation consistent with its goals. The Administration has set an ambitious 
timeline—calling for action on legislation during its first year. 
 
This report examines several policy options that could improve the value of the 
nation’s investment in the health care delivery system and help finance federal support of 
coverage expansions. To illustrate the importance of the structure and details of the 
policy options, it presents a range of estimates from three different sources: 1) estimates 
prepared for The Commonwealth Fund by the Lewin Group and published in a recent 
report, The Path to a High Performance U.S. Health System: A 2020 Vision and the 
Policies to Pave the Way (the Path report); 2) estimates by the Office of Management and 
Budget (OMB) for the president’s budget proposal, the economic stimulus bill, and 
additional savings proposed in June 2009; and 3) estimates by the Congressional Budget 
Office (CBO). The discussion and comparisons focus on policy options that were examined 
by the three sources. All estimates consider the potential impact over 10 years, 2010–19. 
 vi
 The estimates of the potential impacts different policies would have indicate that 
there is potential for significant gains. As shown in this report, the available estimates 
differ primarily in terms of the scope of the policies and particular elements of the proposals. 
 
As the health care reform debate unfolds, it will be important to keep in mind that 
there are various options for financing the necessary federal investment and stimulating 
change throughout the care system. The challenge will be building consensus to move 
forward and implement policies that have the potential to simultaneously address health 
care access, quality, and costs. 
 
Comparing the Budget Impact of Select Policy Options 
Changes to Medicare Advantage  
• OMB budget estimate: $175 billion federal savings 
• CBO estimate: $157 billion federal savings for setting benchmark at local  
fee-for-service rates; $158 billion federal savings for competitive bidding 
• Path estimate: $135 billion federal savings 
Achieving Lower Drug Costs in Public Programs 
• OMB budget estimate: $104 billion federal savings 
• CBO estimate: $110 billion federal savings 
• Path estimate: $93 billion federal savings, $62 billion total health system savings 
Bundle Payments for Hospitals to Include Post–Acute Care and Productivity Adjustments  
in Medicare Updates 
• OMB budget estimate: $26 billion federal savings for bundling acute and post-acute care 
payments, $110 billion federal savings for incorporating productivity adjustments into 
Medicare updates 
• CBO estimate: $19 billion federal savings for bundling acute and post-acute care 
payments, $102 billion federal savings for incorporating productivity adjustments into 
Medicare updates 
• Path estimate: $123 billion federal savings, $182 billion total health system savings 
Changes to Home Health Reimbursement 
• OMB budget estimate: $37 billion federal savings 
• CBO estimate: $50 billion federal savings 
• Path estimate: Not available 
Modify Updates for Non-Acute Care Facilities 
• OMB estimate: Not available 
• CBO estimate: $24 billion federal savings 
• Path estimate: Not available 
 
Hospital Pay-for-Performance 
• OMB budget estimate: $12 billion federal savings 
• CBO estimate: $3 billion federal savings 
• Path estimate: $43 billion federal savings, $55 billion total health system savings 
 vii
 Patient-Centered Medical Homes 
• OMB budget estimate: Not available  
• CBO estimate: ($6 billion federal budget) 
• Path estimate: $83 billion federal savings, $144 billion total health system savings 
Primary Care Payment and Physician Payment Reform 
• OMB budget estimate: Not available 
• CBO estimate: $5 billion federal savings 
• Path estimate: $23 billion federal savings, $56 billion total health system savings 
Health Information Technology 
• ARRA estimate: $13 billion federal savings 
• CBO estimate: $4 billion federal savings through incentives, $61 billion if HIT use were 
required as condition of participation in Medicare 
• Path estimate: $70 billion federal savings, $180 billion total health system savings 
Comparative Effectiveness Research 
• ARRA estimate: Not available 
• CBO estimate: ($1 billion federal budget), $8 billion total health system savings 
• Path estimate: $174 billion federal savings, $480 billion total health system savings 
High-Cost Area Update 
• OMB budget or ARRA estimate: Not available 
• CBO estimate: $51 billion federal savings 
• Path estimate: $100 billion federal savings, $177 billion total health system savings 
Reduce Subsidies to Hospitals for Treating Uninsured as Coverage Increases 
• OMB estimate: $106 billion federal savings 
• CBO estimate: Not available 
• Path estimate: $9 billion federal savings in 2010 alone, 10-year estimate not available 
 
Manage Physician Imaging 
• OMB estimate: Not available 
• CBO estimate: $1 billion federal savings for requiring prior authorization for imaging, $3 
billion federal savings for increasing the equipment utilization factor in payment updates 
• Path estimate: $23 billion federal savings, $29 billion total health system savings 
 
Reduce Waste, Fraud, and Abuse 
• OMB estimate: Not available 
• CBO estimate: $0.5 billion federal savings 
• Path estimate: Not available 
 
Select Population Health Options 
• ARRA estimate: Not available 
• CBO estimate: $205 billion federal revenues (2009–18 period) 
• Path estimate: $247 billion federal savings, $583 billion total health system savings 
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 FINDING RESOURCES FOR HEALTH REFORM  
AND BENDING THE HEALTH CARE COST CURVE 
 
 
THE PRESIDENT’S HEALTH REFORM RESERVE FUND: A CRITICAL DOWNPAYMENT 
In February 2009, President Obama sent his first budget to Congress. The budget outlined 
the new Administration’s priorities for health reform: 
• protecting families’ financial health; 
• ensuring that health coverage is affordable; 
• aiming for universality in coverage; 
• providing portability of coverage; 
• guaranteeing consumer choice; 
• investing in prevention and wellness; 
• improving patient safety and the quality of care; and 
• maintaining long-term fiscal sustainability. 
 
Consistent with the president’s belief that health reform should be financially 
sustainable, he included a $634 billion reserve fund to advance reform over the next 
decade, 2010–19. The proposed reserve fund includes a roughly equal mix of increased 
revenues ($318 billion) and reductions in federal spending ($316 billion) through 
payment reforms.1 In June 2009, the White House released proposals for an additional 
$313 billion in savings. The budget proposal builds on the $150 billion investment 
included in the American Recovery and Reinvestment Act (ARRA, or economic stimulus 
package) enacted in February 2009. Specifically, ARRA included $19.2 billion for health 
information technology and $1.1 billion to support generating better information for 
patients and clinicians on the comparative effectiveness of different medical treatments. 
While the reserve fund would make a substantial commitment to health reform, both the 
proposed revenues and reductions in spending are controversial and face an uphill battle 
in Congress. Even if it wins support from Congress, the reserve fund would fall short of 
what would be required to achieve health insurance for all and to make critical health 
system reforms. A variety of estimates indicate that this type of comprehensive reform 
would require more than $1 trillion over the next decade.2
 
In a departure from the past, the Administration has left the details of the health 
reform legislation to Congress, looking largely to the committees of jurisdiction to 
develop legislation consistent with its goals. The Administration has set an ambitious 
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 timeline—calling for action on legislation during its first year. Congressional leaders 
have responded by holding a series of roundtables, hearings, and meetings with key 
stakeholders in an effort to prepare legislation that could be ready for floor action by the 
summer of 2009. 
 
In both the House and Senate, the committees of jurisdiction have taken 
unprecedented steps to coordinate their efforts. The Senate Finance Committee and the 
Health, Education, Labor, and Pensions Committee have committed to working in 
tandem on health reform legislation; in the House, the three committees of jurisdiction 
(Ways and Means, Energy and Commerce, and Education and Labor) have committed 
publicly to producing similar health reform legislation. The budget resolution adopted by 
Congress in April 2009 largely included the principles laid out in the president’s budget 
and a deficit-neutral reserve fund for health reform, although the amount of the reserve 
fund was unspecified. Under the budget resolution, the committees of jurisdiction were 
instructed to identify ways to finance their reform proposals, prompting congressional 
leaders to reach agreement not only on substantive policy proposals and legislative 
changes but also on how to pay for comprehensive reform. 
 
Developing the Budget Resolution 
In most years, the president submits to Congress a detailed budget request for the coming 
federal fiscal year (beginning October 1) on or before the first Monday in February. This 
detailed request has three main roles: to convey to Congress what the president recommends 
for overall fiscal policy, including levels of tax revenue and public spending; to lay out the 
president’s priorities for federal programs; and to signal to Congress what spending and tax 
policy changes the president recommends. The president’s budget request must include a 
discretionary spending request each year, and may also include changes to entitlement 
programs and the tax code. 
After receiving the president’s budget request, Congress holds various hearings and develops 
its own budget resolution. Initially, the House and Senate work separately and the two Budget 
Committees draft their own resolutions. Once the House and Senate resolutions are passed in 
their respective chambers, a conference is held to resolve any differences and both chambers 
vote on the conference report. Unlike an ordinary bill, the budget is a concurrent resolution 
that does not go to the president for his signature or veto, only requires a majority to pass,  
and cannot be filibustered in the Senate. The budget resolution itself is not detailed like the 
president’s budget request, but establishes spending targets or limits for 19 broad spending 
areas through outlays and budget authority, and outlines total revenue collected for the next 
five years. Greater detail about the assumptions made in developing the budget (e.g., how  
a certain program may be cut or expanded) is specified in the report accompanying the  
final resolution. 
 
OPTIONS FOR FUNDING COMPREHENSIVE REFORM 
This report examines several policy options that could improve the value of the nation’s 
investment in the health care delivery system and help finance federal support of 
coverage expansions. To illustrate the importance of the structure and details of the 
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 policy options, it presents a range of estimates from three different sources: 1) estimates 
prepared for The Commonwealth Fund by the Lewin Group (Lewin) and published in a 
recent report, The Path to a High Performance U.S. Health System: A 2020 Vision and 
the Policies to Pave the Way (the Path report); 2) estimates by the Office of Management 
and Budget (OMB) for the president’s budget proposal and the economic stimulus bill, 
and additional savings proposed in June 2009; and 3) estimates by the Congressional 
Budget Office (CBO).3 The discussion and comparisons focus on policy options that 
were examined by the three sources. All estimates consider the potential impact over  
10 years, 2010–19.4
 
All three sources focus on the potential savings compared with projected cost 
trends (i.e., bending the cost curve) if the policies were adopted by federally sponsored 
programs. In the Path report estimates, the policies would apply to a reformed health 
insurance market in which a new, federally sponsored public health insurance option 
would be available to the under-65 population through a national insurance exchange. As 
a result, savings estimates apply to the current Medicare or Medicaid programs as well as 
to populations enrolled in the new public insurance plan. 
 
Estimates from the Administration’s budget and economic stimulus legislation 
(ARRA), the Path report, and CBO indicate that early investments could yield significant 
reductions in total health care spending over time through gains in the quality and 
efficiency of care. The three sources provide a rich menu of policy options and approaches. 
Table 1 summarizes select policy options and the resulting estimates of potential federal 
savings or increases in revenues over a 10-year period, compared with the projected cost 
growth trend. Reforms estimated to increase federal spending or reduce revenue compared 
with the projected cost trend are noted in parentheses to indicate negative amounts. 
 
Typically, federal budget proposals and CBO estimates focus only on the 
estimated effect on federal spending and do not estimate the potential impact on total 
national health expenditures (NHE). Because the policy options examined here seek to 
improve the health system for the nation and have direct impact on state revenues as well 
as on households and employers, the Path report looked at potential savings in terms of 
both federal and national health spending. As this report shows, federal reforms have the 
potential to produce substantial total health system savings for the nation—well beyond 
what is reflected in the estimated federal budget impact. 
 
Table 1 groups similar reform proposals for ease of comparison. However, the 
estimated savings often vary significantly because of significant differences in elements 
of the proposals. The discussion below examines several policies in depth to highlight 
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 such differences and the assumptions that underlie the estimates. The comparisons 
illustrate that the way policy options are structured greatly affects their estimated budgetary 
impact.5 Although there are differences among the estimates, there are several common 
approaches being discussed to identifying funding for comprehensive health reform. 
Unless noted, estimates refer to potential federal savings over a 10-year period, 2010–19. 
 
Table 1. Potential Sources of Federal Savings and Revenue  
Compared with Projected Trends, Cumulative, 2010–2019 
 
OMB:  
Budget  
and ARRA CBO 
Path 
(Federal) 
Path 
(Total Health 
System)* 
Savings $ Billions $ Billions $ Billions $ Billions 
Revise Medicare Advantage 
Benchmarks $175 $157 or $158 $135 — 
Reduce Prescription Drug Costs $104 $110 $93 $62 
Payments for Hospital Episodes to 
Include Post–Acute Care and 
Productivity Updates in Medicare 
$26 or $110 $19 or $102 $123 $182 
Modify the Home Health Update Factor $37 $50 — — 
Modify Updates for Skilled Nursing 
Facilities, Inpatient Rehabilitation 
Facilities, and Long-Term Care 
Hospitals 
— $24 — — 
Hospital Pay-for-Performance $12 $3 $43 $55 
Patient-Centered Medical Homes — ($6) $83 $144 
Primary Care Payment Reform — $5 $23 $56 
Health Information Technology Adoption $13 $4 or $61 $70 $180 
Comparative Effectiveness Research 
and Use of Information  — ($1) $174 $480 
Modify High-Cost Area Update — $51 $100 $177 
Reduce Subsidies to Hospitals for 
Treating Uninsured as Coverage 
Increases 
$106 — $9 — 
Manage Physician Imaging — $1 or $3 $23 $29 
Reduce Waste, Fraud, and Abuse — $0.5 — — 
Select Population Health Options     
Tobacco Excise Tax — $95 $79 $215 
Alcohol Excise Tax — $60 $47 — 
Sugar-Sweetened Beverage Excise Tax 
and Obesity Abatement — $50 $121 $321 
Note: Savings are not additive and policies may have overlapping or synergistic effects. 
* If Lewin did not provide any estimate for a policy or only provided an estimate of impact to the federal budget,  
the Total Health System column is left blank. 
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 COMPARISON OF SELECT POLICY OPTIONS 
Changes to Medicare Advantage 
• OMB budget estimate: $175 billion federal savings 
• CBO estimate: $157 billion federal savings for setting benchmark at local fee-for-
service rates; $158 billion federal savings for competitive bidding 
• Path estimate: $135 billion federal savings 
 
Current Policy 
The current method of setting benchmarks for payments to Medicare Advantage (MA) 
plans results in payments estimated to average 13 percent higher than costs would have 
been under traditional Medicare fee-for-service (FFS) plans. In 2009, this translated into 
a projected $11 billion in extra costs to the federal government, bringing the total extra 
payments to MA plans from 2004–09 up to nearly $44 billion. Under the current method 
for determining payments, plans submit bids for covering Medicare beneficiaries based 
on their expected costs for providing coverage. The bid is then compared with benchmark 
rates for each county and national rates. 
 
If a plan’s bid is below the benchmark, the plan receives a payment equal to the 
amount of the bid plus 75 percent of the difference between the bid and the benchmark. 
These additional funds must be returned to beneficiaries through additional services or 
premium reductions. If the plan’s bid is at or above the benchmark, the plan receives the 
benchmark amount. In many geographic areas, benchmarks are well above costs expected 
under traditional Medicare. By 2008, benchmarks in nearly a third of counties were on 
average 10 percent higher than local FFS spending. As a result, the current method of 
setting benchmarks and contracting with plans sends a price signal that encourages higher 
rather than lower costs. 
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 Budget Reconciliation 
The budget reconciliation process is a tool designed to reduce the deficit by forcing 
committees to produce spending cuts or raise tax revenue called for in the budget resolution 
(although it was used several times during the George W. Bush Administration to enact tax 
cuts). A reconciliation bill is a single piece of legislation that typically includes multiple 
provisions, all of which affect the federal budget. This type of legislation may not be 
filibustered in the Senate and only requires a majority vote to pass. If Congress decides to use 
this procedure, the budget resolution must include a reconciliation directive instructing a 
committee to produce legislation by a certain date that meets certain spending or tax targets. 
All of these bills are packaged for a single floor vote with limited opportunity for amendment, 
differences between the House and Senate versions are resolved in conference, and the final 
conference report is considered in both chambers before going to the president for signature 
or veto. The Byrd rule constrains the reconciliation process so that, of the bundle of bills 
considered on the floor, any provision deemed extraneous to the purpose of amending 
entitlement or tax law is vulnerable to a point of order, thereby stripping that provision from the 
bill unless at least 60 senators vote to waive the rule. The Byrd rule also prohibits any 
entitlement increases or tax cuts that cost money beyond the five years covered by the 
reconciliation directive, unless these costs are fully offset by other provisions in the bill. 
Independent of the budget process is the “Pay-As-You-Go” rule, or “PAYGO,” which requires 
that all entitlement increases or tax cuts be fully offset. For example, a House or Senate bill 
that increases Medicare spending would have to be paid for by cutting somewhere else in 
Medicare or another entitlement program, by raising revenues, or by a combination of the two. 
If no offsets are included in legislation, any senator may raise a point of order against the bill, 
which can be waived by the vote of 60 senators. In the House, any member can raise a point 
of order, and there is no mechanism to waive the rule—the bill is automatically defeated 
unless the leadership-appointed Rules Committee decided in advance to waive PAYGO as 
part of a broader measure setting the terms of debate on the bill. 
 
OMB Option 
The Administration’s budget includes a provision that would establish competitive 
bidding for MA that would determine payment levels based on an average of bids 
submitted rather than current benchmarks. The budget proposal estimates that allowing 
the market to set limits would reduce Medicare outlays by $175 billion over the 2010–19 
period as well as reduce Part B premiums for beneficiaries. 
 
CBO Option 
The first CBO option would modify the payment mechanism to establish a benchmark. 
This option would set the benchmark in each county to equal the projected local per 
capita spending for traditional FFS spending, beginning in 2011. CBO estimated that this 
would yield $157 billion over the 2010–19 period. 
 
A second CBO option would replace the existing MA payment mechanism with a 
system in which benchmarks would be determined solely by plans’ bids, which reflect the 
per capita payment they would accept for providing benefits covered by Medicare. The 
benchmark for each county would be the average bid of the plans that served that county, 
with each bid weighted by its enrollment the previous year. Beneficiaries who enrolled in 
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 a plan with a bid below the county’s benchmark would receive the full difference 
between the bid and the benchmark in the form of additional benefits or a rebate on their 
Part B premium. Beneficiaries who enrolled in a plan with a bid above the county’s 
benchmark would pay the full difference between the benchmark and the bid in 
additional premiums. CBO estimated that this option would yield $158 billion in savings 
over the 2010–19 period. 
 
Path Option 
The Path option would recalibrate the benchmark rate to the FFS per capita costs, 
eliminating excess payment due to the differences between the existing benchmark rate 
and the FFS per capita costs. Lewin estimates that this change would yield a reduction in 
federal spending of $135 billion over the 2010–19 period. 
 
Comparison 
Although the policy options take different approaches, all three seek to recalibrate the 
method of reimbursing MA plans to promote more efficient care. The Path option and the 
first CBO option are very similar; both use county-based FFS per capita costs as a new 
benchmark. These options, in effect, would return to earlier payment policies that 
rewarded plans that could deliver high-quality care and costs below current Medicare fee-
for-service levels. Unspecified differences in the assumptions (e.g., the estimated number 
of Medicare Advantage enrollees, timing for phasing in a new benchmark) account for 
the slight difference in estimates of savings. Plans with bids well above average costs 
would be at a competitive disadvantage. The second CBO option and the option in the 
Administration’s budget proposal would compare plan bids within geographic areas, 
promoting efficiency by allowing plans to bid based on their projected costs rather than 
using bids below the current benchmark to turn a profit. 
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 President Obama’s First Budget Request 
A major indication of the Administration’s commitment to achieving health reform was the 
inclusion of a $634 billion health care reform reserve fund in the budget request released in 
February 2009 and additional $313 billion from a supplement released in June 2009. To 
ensure budget neutrality over the coming decade, 2010–19, the Administration proposed a 
two-part funding mechanism for this reserve fund: a reduction in the itemized deduction rate 
for families with incomes over $250,000 per year, and realized savings of $316 billion over 10 
years from policy changes in the Medicare and Medicaid programs. These changes would 
deliver an estimated: 
• $177 billion from Medicare Advantage; 
• $110 billion from productivity updates in Medicare; 
• $106 billion from reducing disproportionate share payments as coverage increases; 
• $104 billion from prescription drug price reforms; 
• $ 37 billion from modifying the home health update; 
• $ 26 billion through incentives to reduce hospital readmissions; 
• $ 12 billion through hospital pay-for-performance rewards; and 
• $ 22 billion from other policy options. 
In total, the major health provisions specified in the budget save $622 billion over 10 years 
and generate new revenues of $326 billion from tax changes affecting high-income 
households. While the proposed reserve fund represents a substantial commitment to moving 
forward on reform, the revenue and savings proposed fall short of what would be required to 
achieve health insurance for all. 
Although the Administration’s request was silent on whether Congress should consider using 
reconciliation to pass a health reform bill, the final budget resolution passed by Congress did 
include such instructions. Congressional leaders have indicated that it is their preference to 
pass comprehensive health reform in a bipartisan manner but may resort to using the 
reconciliation tool if bipartisan negotiations are unsuccessful. In April 2009, Senator Arlen 
Specter of Pennsylvania switched from the Republican to the Democratic Party, giving  
the majority 59 votes in the Senate. As of June 2009, legal challenges to the Minnesota 
election results were still under way, but if Al Franken is ultimately seated as a senator for 
Minnesota, the Democrats will have a filibuster-proof majority and may not need to use the 
reconciliation process. 
 
Achieving Lower Drug Costs in Public Programs 
• OMB budget estimate: $104 billion federal savings 
• CBO estimate: $110 billion federal savings 
• Path estimate: $93 billion federal savings, $62 billion total health system savings 
 
Current Policy 
Prescription drug costs currently account for more than a fifth of total national health 
spending and have been increasing rapidly. International comparisons as well as 
experience within the United States indicate that there is potential to lower spending in 
public programs by using purchasing leverage, especially for unique, expensive 
medications. The Veteran’s Administration and other federal programs have mechanisms 
in place to achieve cost-effective acquisition of drugs. Medicaid uses manufacturer 
rebates and Medicare allows Part D plans and MA plans with prescription drug coverage 
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 to negotiate prices directly with manufacturers. A variety of policy options would seek 
further savings through the expansion of economies of scale and leverage of group 
purchasing through federal programs. 
 
OMB Option 
The Administration’s budget proposes reducing Medicaid drug prices by increasing the 
Medicaid brand-name drug rebate from 15.1 percent to 22.1 percent of the average 
manufacturer price. The larger rebate would apply to new drugs and would be available 
to Medicaid managed care organizations as well as state Medicaid FFS programs. The 
budget proposal estimates this expansion of the rebate would yield $20 billion in federal 
savings over the 2010–19 period. In addition, the Administration’s budget proposes 
changing the regulations for approval of biologic drugs to establish a process for 
affordable follow-on biologics (i.e., a new version of an existing biopharmaceutical that 
uses the same mechanism of action and treats the same clinical indications as the original, 
though not truly “generic”) or generic drugs. This would save an estimated $9 billion 
over the 10-year window. The Administration also proposed a third option to reduce 
prescription drug reimbursement rates for beneficiaries dually eligible for Medicare and 
Medicaid. This would save an estimated $75 billion over the 10-year window, totaling 
$104 billion federal savings from all three provisions. 
 
CBO Option 
The CBO option would create a Medicare drug rebate policy modeled on the existing 
Medicaid rebate for purchases of brand-name drugs by all Part D beneficiaries, requiring 
manufacturers of brand-name drugs to provide a rebate to the federal government 
equaling 15 percent of the average manufacturer price. This would produce estimated 
savings of $110 billion over the 10-year period. Various congressional proposals have 
called for allowing the Secretary of Health and Human Services (HHS) to have broader 
negotiation authority. CBO did not include an estimate of costs or savings from allowing 
the Secretary to negotiate drug prices for Part D in its December 2008 report. However, 
CBO did analyze such a provision in legislation from the 110th Congress. Senate bill 3 
(S. 3) would have revised the “noninterference clause” of the Medicare Modernization 
Act Part D legislation to allow the Secretary to negotiate prices or join negotiations 
between drug manufacturers, pharmacies, private drug plan (PDPs), or sponsors. The 
proposal would have restricted the Secretary from instituting a formulary or price 
structure for Part D drugs, and would have allowed PDPs to negotiate lower prices than 
those negotiated by the Secretary. CBO estimated that striking the non-interference 
provision as proposed would have had a negligible effect on federal spending, because it 
anticipated the Secretary would not have leverage to negotiate rates lower than those 
currently negotiated by PDPs. 
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 Path Option 
The Path policy options would authorize the Secretary to set or negotiate the price of 
therapeutically unique, expensive drugs using prices paid internationally as the target 
range. Policies in the Path report also would focus on beneficiaries who are dually 
eligible for Medicare and Medicaid and have high rates of chronic disease, allowing the 
Secretary to establish a multi-payer purchasing collaborative open to all public payers 
and multi-employer private purchasing groups. For the dually eligible group, drug 
manufacturers would be required to give the full Medicaid rebate to current Part D and 
MA plans. Lewin estimates that this change would yield $90 billion in federal 
government savings over the 2010–19 period and a $57 billion net reduction in national 
health spending over the same period. 
 
Giving the Secretary authority to negotiate lower prices for prescription drugs for 
federal programs, including Medicare, would focus on the average global price for single-
source drugs for which there are no therapeutic alternatives—a category in which current 
Part D plans have been relatively unsuccessful in containing costs. Lewin estimates that 
such negotiations could yield $3 billion in federal savings and a $5 billion net reduction 
in national health spending over 10 years. 
 
Comparison 
While all of these policy options target areas in which current U.S. prescription drug 
spending is high, they take different approaches to achieve savings. The Administration’s 
budget option would simply increase the Medicaid drug rebate and apply this rebate to 
dually eligible beneficiaries, reducing the costs of drugs for Medicaid beneficiaries. In 
contrast, the Path policies would focus on prices paid for medications for the chronically 
ill and promote broad price negotiations. The CBO option would apply the current rebate 
to all brand-name drugs purchased through a PDP or Medicare Advantage Prescription 
Drug Plan, expanding the population to which the rebates would apply. 
 
The policy option allowing the HHS Secretary to negotiate drug prices was not 
included in the Administration’s budget, though in recent years there have been 
numerous legislative attempts in Congress to give the Secretary this ability. Although the 
CBO estimates of a policy option weaker than the Path options assumed that the 
Secretary would not have sufficient leverage to obtain prices lower than what PDPs 
currently obtain, the Path policies focus on an area where PDPs have been unsuccessful 
in lowering prices—namely, non-competing single-source drugs—and allow the 
Secretary to use global prices at targets. Lewin assumed that despite drug manufacturers’ 
monopoly position with these drugs, they may be willing to agree to discounts to avoid 
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 negative public opinion. In an April 2007 letter to Senator Ron Wyden (D–Ore.), CBO 
indicated that this type of limited negotiating by the Secretary could achieve lower prices 
but that the likely effect would be modest, a conclusion consistent with Lewin’s estimate 
of prospective savings. 
 
Bundle Payments for Hospitals to Include Post–Acute Care 
• OMB budget estimate: $26 billion federal savings for bundling hospital payments 
for inpatient acute care and targeted post-acute care; $110 billion federal savings 
for permanently reducing Medicare payment updates by half of expected 
productivity gains 
• CBO estimate: $19 billion federal savings for bundling inpatient acute care, 
readmissions, and post-acute care within 30 days; $102 billion federal savings for 
reducing Medicare payment updates by the half of expected productivity gains 
• Path estimate: $123 billion federal savings, $182 billion total health system savings 
 
Current Policy 
The Medicare FFS program currently pays hospitals fixed amounts for each hospital 
admission/discharge based on the diagnosis and risk adjustments. Paying a bundled rate 
for the inpatient hospital stay up to the time of discharge would create an incentive for 
hospitals to provide efficient care. However, such payments would not support or provide 
incentives for hospitals to help patients during their transitions home or to post–acute 
care settings; neither would they support or provide incentives for hospital to ensure that 
patients receive follow-up care. As a result, hospitals lack financial support or incentives 
to take measures to prevent complications that could lead to rehospitalizations. One way 
to align incentives, provide better care for vulnerable patients, and prevent readmissions 
would be to expand the scope of bundled payments to encompass acute hospital care and 
post–acute care and hold hospitals accountable for the costs of the initial hospitalization 
and readmissions. With estimates that as many as 75 percent of readmissions may be 
preventable, such policy options have the potential to improve patient care and lower 
health care costs. 
 
OMB Option 
The Administration’s budget would bundle hospital payments for inpatient acute care and 
targeted post–acute care providers for the 30 days after hospitalization. Hospitals with 
high rates of readmission would be paid less if patients are readmitted within 30 days. 
The Administration expects reduced readmissions to save $8 billion and increased 
efficiency in post–acute care to save $18 billion over the 2010–19 period, totaling $26 
billion in savings. In addition, the Administration proposed a permanent adjustment to 
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 most annual Medicare payment updates by half of the economy-wide productivity factor to 
encourage greater efficiency and more accurately align Medicare payments with provider 
costs. This provision would save an estimated $110 billion over the 2010–19 period. 
 
CBO Options 
The first CBO option would expand the unit of payment for acute care provided in 
hospitals to include post–acute care provided in acute care hospitals and non-hospital 
settings, defined as any service initiated within 30 days of a patient’s discharge from an 
acute care inpatient hospital provided by specific types of post–acute care providers 
including skilled nursing facilities and home health care agencies. Hospitals would 
receive a single bundled payment from Medicare for these services, regardless of whether 
a particular patient received post-acute care. Medicare would no longer make separate 
payments for post–acute care services following an acute care inpatient stay. This policy 
would likely reduce the cost of post–acute care services for Medicare beneficiaries 
through reductions in the volume or intensity of post–acute care or through hospitals’ 
contracting with more efficient providers. The policy seeks to improve patient outcomes 
through greater coordination of post-discharge and post–acute care. Hospitals would 
retain 20 percent of the anticipated savings and the remainder would be recaptured 
through adjustments in Medicare’s annual update factors. This would yield an estimated 
$19 billion in reduced mandatory spending. 
 
A second option considered by CBO would reduce annual updates in Medicare 
fee-for-service payments to reflect expected productivity gains. For acute care hospitals, 
home health agencies, hospices, inpatient rehabilitation centers, inpatient psychiatric 
facilities, long-term-care hospitals, outpatient facilities, and skilled nursing facilities, this 
policy would implement an annual update beginning in 2011 equal to the market-basket 
index (MBI) minus half of the expected productivity gains. This would better align 
Medicare payments with the cost of care and promote more efficient provision of care 
while allowing providers to share in the savings associated with productivity gains. CBO 
estimates that this would save $102 billion over the 10-year window. 
 
Path Option 
The Path option follows a similar approach to the CBO policy option to expand the 
current hospital bundle to cover the costs of readmissions and post–acute care. For all 
inpatient prospective payment system hospitals and their associated integrated care 
networks, Medicare would bundle payments encompassing inpatient care, inpatient 
physician services while hospitalized, readmission care, and post–acute care services 
provided up to 30 days after the discharge date, including skilled nursing facility and 
home health care. The policy would be staged: expanding first to readmission care, then 
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 post–acute care, and finally to inpatient physician services. The initial payment amounts 
would be calculated as a percentage of the current mean payments for each component of 
the bundle, yielding 15 percent savings for readmissions, 10 percent savings for post–
acute care, and 5 percent savings for inpatient physician and emergency department care. 
In future years, the update factor would be reduced each year to account for improved 
integration of care. The update would be reduced by 0.5 percentage point in 2010–12, 
0.75 percentage point in 2013–15, and 1.0 percentage point starting in 2016 as greater 
efficiency is achieved over time. Lewin estimates that this policy would yield $123 
billion in federal savings and $182 billion in total health system savings. 
 
Comparison 
The differences among the three estimates of savings stem from the scope of and 
approach to bundling and from policies related to payment updates. The CBO estimate 
assumes the expanded bundled payment rate would be updated with the current update 
factors, less the savings adjustment, while the Lewin estimate includes annual decreases 
to the update factors. Without this reduction, Lewin estimates that bundling would yield 
$74 billion in federal savings. However, when incorporating the CBO and OMB options 
to bundle payments and to incorporate productivity gains into Medicare updates, 
estimates of savings are very similar. 
 
The Path option would be applied to the Medicare program and a new public 
health insurance plan option offered through a national insurance exchange to the under-
65 population. In contrast, the Administration’s budget option and the CBO option would 
only apply to Medicare. Of the net $182 billion saved through this option, Lewin 
estimates $115 billion would come from Medicare savings. The CBO option would set 
the expanded bundled payment rate at the current average cost across all post–acute care 
settings for treating patients in that Medicare severity diagnosis-related group, whereas 
the Path option sets the expanded bundled payment rate lower than what Medicare 
currently pays on average. The CBO option would apply to one-third of post–acute care 
admissions beginning in 2013 and to all admissions beginning in 2015. In contrast, the 
Path option would apply to all admissions beginning in 2010. The policy proposal in the 
Administration’s budget would target reductions in the costs of post–acute care as well as 
readmission rates. 
 
Changes to Home Health Reimbursement 
• OMB budget estimate: $37 billion federal savings 
• CBO estimate: $50 billion federal savings 
• Path estimate: Not available 
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 Current Policy 
Home health agencies currently receive a single, prospectively determined payment to 
cover all of a beneficiary’s services for a 60-day period. This single amount is determined 
by a national base payment rate adjusted to account for differences in patients’ medical 
conditions and functional status (“case mix”) and for geographic variation in the prices of 
inputs such as wages. The base payment is updated annually based on the projected 
increase in the home health market basket index, which reflects increases in the prices of 
inputs. Among freestanding home health agencies, the excess of Medicare’s payments 
over and above providers’ costs totaled 15 percent of Medicare payments in 2006. 
 
OMB Option 
The Administration’s budget option would adjust home health payments to align with 
costs. The budget does not specify the mechanisms to achieve this alignment and the 
corresponding $37 billion in savings, but it is likely that the estimate is based on the 
recommendations of the Medicare Payment Advisory Commission (MedPAC) from its 
March 2009 Report to the Congress. MedPAC made three recommendations: eliminate 
the market basket index update to reduce 2010 payment rates by 5.5 percent from 2009 
levels; re-base rates for home health care services in 2011 to reflect the average cost of 
providing care; and assess payment measures that protect the quality and efficiency of 
care. The recommended changes seek to address excess payments in light of the 
MedPAC analysis that home health payments have been more than adequate in recent 
years. The first recommendation is estimated to save between $5 billion and $10 billion 
over the 2010–14 period, with additional unspecified savings stemming from the 2011 
payment re-base. The third recommendation yields no estimated costs or savings. 
 
CBO Option 
The CBO option would eliminate the market basket index update. This component of the 
update increased by 0.25 percent in 2008, but the proportion of Medicare payments in 
excess of providers’ costs remained at 11 percent. Payments would continue to be 
adjusted for geographic variation and case mix. CBO estimates that eliminating the 
market-basket-index component of the update would yield $12 billion over five years and 
$50 billion over the 2010–19 period. 
 
Path Option 
The Path policies did not include specific changes to home health reimbursement. 
 
Comparison 
The CBO option is similar to the first MedPAC option, but the MedPAC option resets the 
base rate in 2011 based on the average costs of providing care. The Administration’s 
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 budget does not specify the mechanisms it used to achieve the $37 billion estimate of 
savings from realigning home health payments with costs, but it is likely that the 
provisions considered were similar to the MedPAC recommendations and CBO option. 
 
Modify Updates for Non-Acute Care Facilities 
• OMB estimate: Not available 
• CBO estimate: $24 billion federal savings 
• Path estimate: Not available 
 
Current Policy 
Non-acute care facilities such as skilled nursing facilities (SNFs), inpatient rehabilitation 
facilities (IRFs), and long-term care hospitals have been the focus of proposals to reduce 
Medicare spending and improve the quality of care. In March 2009, MedPAC found  
that Medicare payments to these non-acute care facilities were more than adequate to 
cover the cost of care but wide variations in quality persisted. Reducing the payment 
updates for these facilities could encourage quality improvements and efficiency while 
containing costs. 
 
OMB Option 
The Administration option would implement MedPAC’s recommendations for 2010 
payment to SNFs, IRFs, and long-term care hospitals. Payments would be updated based 
on MedPAC’s consideration of multiple variables, such as quality, access to care, and 
adequacy of payment. OMB did not provide a specific estimate for this option, but 
included it in a summary category yielding a total of $22 billion in savings to the federal 
government over the 2010–19 period.  
 
CBO Option 
CBO considered an option to slightly reduce the update factor for SNFs. This would set 
the update factor equal to the market basket index minus one percentage point each year 
from 2011 through at least 2019. CBO estimates this would yield $24 billion in federal 
savings over the 10-year period. 
 
Path Option 
The Path policies did not include modifications to the update factor for non-acute care 
facilities beyond home health agencies, and Lewin did not provide a corresponding estimate. 
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 Comparison 
The main differences between the OMB and CBO options are the scope and amount of 
the update modification. The OMB option would eliminate the updates for three kinds of 
non-acute care facilities in 2010 but reinstate them after that year, reducing the impact of 
the modification. In contrast, the CBO option would reduce the update for SNFs each 
year for at least 10 years, likely resulting in much greater savings. 
 
Hospital Pay-for-Performance 
• OMB budget estimate: $12 billion federal savings 
• CBO estimate: $3 billion federal savings 
• Path estimate: $43 billion federal savings, $55 billion total health system savings 
 
Current Policy 
Pay-for-performance initiatives focused on hospitals have sought to reward and support 
providers to improve the quality of care and achieve better outcomes. Incentives are 
designed to drive improvement as well as achieve benchmark performance levels. These 
initiatives can achieve savings through the reduced cost of higher-quality care and 
through decreased payments or payment updates for hospitals that do not achieve 
benchmark performance levels. The magnitude of savings achieved is linked to the 
magnitude of these reductions. The CMS/Premier Hospital Quality Incentive Demonstration 
(Premier) began in 2003 and aims to promote quality improvement in acute care hospitals 
by expanding the public quality reporting system and providing financial incentives to 
improve. The program now applies to five conditions: acute myocardial infarction, 
isolated coronary artery bypass graft, heart failure, community-acquired pneumonia, and 
hip and knee replacement surgery. A participating hospital receives a 1 percent or 2 
percent bonus for performing at or above the 80th or 90th percentile, respectively, for a 
condition; similarly, a hospital receives a 1 percent or 2 percent penalty for performing at 
or below the 20th or 10th percentile, respectively, in the previous two years. 
 
OMB Option 
The Administration’s budget would link a portion of Medicare payments for acute 
inpatient hospital services to hospitals’ performance on certain quality measures. This is 
estimated to save more than $12 billion over the 2010–19 period. 
 
CBO Option 
The CBO option would expand the Premier demonstration to all acute care hospitals. All 
hospitals would receive reduced Medicare payments for the five conditions based on the 
estimates of productivity growth, and top-performing hospitals would be eligible to 
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 receive bonus payments between 0.75 and 1.50 percent. Beyond the initial universal 
reduction in payment for the five conditions, no additional payment reductions would be 
made for hospitals that provided lower-quality care once the initial payment reduction 
was made. CBO estimated that this would reduce federal outlays by $3 billion over the 
2010–19 period. 
 
Path Option 
The Path option would expand the Premier demonstration to all acute care hospitals and 
modify the financial incentives to provide a bonus to hospitals above the 75th percentile 
and eliminate the payment penalty for hospitals in the bottom two deciles. Lewin estimates 
that this would yield $32 billion in savings to Medicare over the 2010–19 period. In 
addition, the performance incentives would be extended to other conditions at the rate of 
5 percent per year. Funding for the bonuses would be derived by reducing the total hospital 
payment to all hospitals by the total projected bonus payments. Lewin estimates that this 
option would increase the savings to $43 billion in federal government savings and result 
in $55 billion net reduction in national health spending over the 2010–19 period. 
 
Comparison 
Although the Administration’s budget does not specify the assumptions used to reach the 
$12 billion estimate, it is likely that the Administration’s budget extends the Premier 
demonstration to other acute care hospitals but does not modify the financial incentives 
or expand the program to include other conditions. The lower CBO estimate likely 
reflects the exclusion of the low-quality financial penalties currently included in the 
Premier demonstration. The Path pay-for-performance option results in greater savings 
than the other estimates because it would expand the program to include additional 
conditions and would apply to Medicare as well as the new public health insurance 
plan—thus affecting a larger patient base and a larger share of total hospital spending. 
 
Patient-Centered Medical Homes 
• OMB budget estimate: Not available 
• CBO estimate: ($6 billion federal budget) 
• Path estimate: $83 billion federal savings, $144 billion total health system savings 
 
Current Policy 
More than half of people with chronic illnesses receive care from three or more 
physicians, with little communication or coordination among these providers. This 
fragmented care can result in duplicate tests, conflicting medical advice, and prescriptions 
for contraindicated medications. The patient-centered medical home is an approach to 
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 primary care organized around the relationship between the patient and the personal 
clinician. First championed by the American Academy of Pediatrics, the medical home is 
broadly defined as primary care that is “accessible, continuous, comprehensive, family-
centered, coordinated, compassionate, and culturally effective.” Rather than being a 
place, a medical home is a way of delivering care that includes five principles: a personal 
physician; whole-person orientation; safe and high-quality care (e.g., evidence-based 
medicine, appropriate use of health information technology); enhanced access to care; 
and payment that recognizes the added value of a patient-centered medical home. 
 
Focusing on coordinated, patient-centered care could improve health outcomes 
and reduce health spending. Related policy options would support a team approach to 
providing medical care and hold practices accountable for providing meaningful access to 
care, effectively managing chronic conditions, and ensuring that care is coordinated. 
 
OMB Option 
The Administration’s budget did not specifically address medical homes. 
 
CBO Option 
The CBO option provides that Medicare beneficiaries with at least two chronic conditions 
could designate a qualified physician as their medical home. Physicians, group practices, 
or clinics could qualify as medical homes by documenting that they have the systems and 
infrastructure in place to provide coordinated and timely, high-quality care. Those 
providers who qualify as medical homes would receive a per-beneficiary monthly 
payment, compensating them for the additional time and other costs associated with 
managing more comprehensive care. This option is expected to cost $6 billion over the 
2010–19 period. Medical homes have the potential to improve the health and health care 
of enrolled beneficiaries, in some cases reducing spending by eliminating duplicated 
services and increasing the quality and efficiency of care. They may increase spending 
for patients who had not been receiving all recommended care. 
 
Path Option 
The Path option would include a new per-patient payment to support increased access to 
primary care services, case management services for patients with complex conditions, 
and a team approach to care. This enhanced payment would be in addition to the 
traditional FFS payments that primary care providers currently receive. Participating 
providers would be required to demonstrate that their practice has capacity to provide 
enhanced, patient-centered care, with an emphasis on their ability to offer accessible, 
appropriate, and coordinated care for patients with chronic conditions and comorbidities. 
 18
 The option has three elements: the new per-patient medical home payment, incentives for 
patients, and incentives for providers. Patients, providers, and the federal government 
would equally share in the savings in total health spending for enrolled groups. 
 
Providers who elect to participate would have the option of two alternative 
payment structures: a mixed capitation and FFS option through which certified practices 
receive a per-person per-month fee in addition to all FFS payments; or a primary care 
medical home option through which certified practices receive a risk-adjusted, global, 
per-person, per-month fee to cover all primary care services. Providers would be eligible 
to receive their share of savings through year-end bonuses based on performance, as 
judged by measures of clinical quality and patient experience. For example, a provider 
might be evaluated by the proportion of patients who are up-to-date with recommended 
preventive services and the percentage of patients with chronic conditions whose 
conditions are adequately controlled. 
 
All Medicare beneficiaries and enrollees in the public plan option for the under-65 
population would be eligible for the program, and Medicaid beneficiaries with chronic 
illnesses would be required to enroll in managed care or a primary care case management 
(PCCM) program. Positive incentives through lower premiums or reduced cost-sharing 
would encourage patients to designate a primary care practice that meets the certification 
requirements of a medical home. Including all three elements, Lewin estimates this 
option would yield $83 billion in federal savings and $144 billion in total health system 
savings between 2010 and 2019. 
 
Comparison 
The CBO estimate does not acknowledge any potential savings from the medical home 
model and includes only the cost of the medical home payment and administration of the 
program. In contrast, the Lewin estimate projects savings from the medical home based 
on evidence from Medicaid PCCM programs, primary care in private managed care 
plans, medical home programs in private FFS plans, and medical home programs in 
integrated delivery systems. The CBO option applies only to Medicare beneficiaries and 
does not include Medicaid beneficiaries or any individuals who would enroll in Path’s 
public plan option. 
 
In addition, the per-member per-month fee varied. The CBO estimate began at 
$34 per month in 2010, with annual adjustments relative to the Medicare physician fee 
schedule, whereas the Lewin estimate for the mixed capitation and FFS option fee would 
average around $8 per month. The Lewin estimates for the global fee were not specified 
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 but would be set at the expected risk-adjusted average payment for primary care services, 
taking into account geographic differences in the prices of practice inputs. 
 
Primary Care Payment and Physician Payment Reform 
• OMB budget estimate: Not available 
• CBO estimate: $5 billion federal savings 
• Path estimate: $23 billion federal savings, $56 billion total health system savings 
 
Current Policy 
In Medicare’s fee-for-service (FFS) program, physicians who treat Medicare 
beneficiaries are paid separately for each service they provide. Currently, cognitive 
services and primary care services are relatively undervalued compared with procedures 
and specialty care. Moreover, annual updates aimed at slowing spending due to higher 
volume for procedures have held down annual updates for primary care physicians and 
generalists, despite the fact that these are not the services that are driving the higher 
volume of procedures. As a result, specialists’ incomes have grown rapidly compared 
with those of primary care providers. Despite our projected growing need for primary 
care providers to serve an aging population, the market signal of lower pay and long 
hours has resulted in fewer graduates of medical school choosing primary care careers 
over specialties each year. Increasing reimbursement for primary care could provide 
better support for primary care, with an emphasis on prevention and taking time to 
manage patients with chronic conditions. Over time, improved payment policies such as 
increased reimbursement could increase the number of primary care providers entering 
the workforce. 
 
OMB Option 
The Administration’s budget did not specify changes to be made to the physician 
payment system, but indicates that the system needs to be reformed to give physicians 
incentives to improve the quality and efficiency of care. The budget describes policies 
that would enable physicians to form voluntary groups that coordinate care for Medicare 
beneficiaries and receive performance-based payments for the coordinated care, but it 
does not estimate a cost or savings from such policies. 
 
CBO Option 
Under the policy option examined by the CBO, each Medicare FFS beneficiary would be 
assigned to a primary care physician (PCP) who would be reimbursed by a partial-
capitation system. PCPs would receive three-fourths of their Medicare payments on a 
per-service basis and approximately one-fourth of their payments through risk-adjusted 
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 capitation; in addition, bonuses or penalties would result based on the total expenditures 
incurred by each PCP’s panel of assigned beneficiaries. This is expected to facilitate 
PCPs’ coordination of care and to reduce the volume and intensity of services provided to 
these beneficiaries, thereby increasing the cost-effectiveness of treatment under Medicare 
FFS. This policy would address some of the disparity between primary and specialty care 
reimbursement, largely by providing an incentive to provide primary care through a 
practice similar to a medical home. CBO estimates this would save the federal 
government $5 billion during the 10-year window. 
 
Path Option 
The Path option would revise the Medicare physician fee schedule to increase payment 
for primary care services by raising the relative value units by 5 percent for primary care 
services provided by “primary care focused” practitioners. This adjustment would be 
budget neutral in the first year through reductions in payments for all other services in 
proportion to the amount increased for the primary care services (an estimated 0.5 percent 
reduction). The Path option also would separate updates for primary care from more 
specialized care and procedures. The policy would apply preferential updates to payments 
for primary care (e.g., generalist, cognitive care) and slow the growth of payments for 
specialized care and procedures. Lewin estimates that the impact of modifying the fee 
schedule would increase payments for primary care by $8 billion over 10 years, while 
simultaneously reducing payments for other specialized services by $25 billion, resulting 
in a net Medicare savings of $17 billion over the 2010–19 period. The changes in value 
could, over time, influence the proportion of physicians going into primary care. Through 
the extension of these payment policies to the new public health insurance option for the 
under-65 population, this policy could yield $23 billion in federal government savings 
and $56 billion in total health system savings over the 2010–19 period. 
 
Comparison 
The Path option would apply to Medicare and those enrolled in the new public health 
insurance option, spanning a larger population than envisioned by CBO. The Lewin 
estimate of the impact of the Path option on Medicare alone projects $17 billion in 
savings over the 2010–19 period, compared with the $56 billion net savings when the 
public health insurance option is included. The CBO and Path options differ in their 
approach to specialized care and procedures. The CBO option would not change payment 
for these services but would reward or penalize the PCP for lower- or higher-than-
average expenditures; it would reduce payment to other providers through the 
gatekeeping functions of the PCP and by decreasing utilization of specialized care and 
procedures. In contrast, the Path option would decrease payment for specialized care and 
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 services to maintain budget neutrality. The Lewin estimate includes a projected initial 
increase in utilization of specialized care and procedures that partially offsets the 
payment reduction. 
 
Health Information Technology 
• ARRA estimate: $13 billion federal savings 
• CBO estimate: $4 billion federal savings through incentives, $61 billion if HIT 
use were required as condition of participation in Medicare 
• Path estimate: $70 billion federal savings, $180 billion total health system savings 
 
Current Policy 
Health information technology (HIT) has the potential to produce savings and improve 
the effectiveness and safety of medical care by increasing the efficiency with which care 
is delivered, reducing duplicative or unnecessary care, and lowering the incidence of 
medical errors. HIT also can improve patient safety through identification of 
contraindicated prescriptions or procedures. Built-in clinical decision tools enable 
providers to use the most up-to-date information when considering treatment options. 
Currently, the pace of adoption and use of HIT has been slow. All of the policy options 
discussed seek to accelerate the spread, effective use, and availability of essential 
information across sites of care. 
 
Stimulus Legislation (ARRA) provision 
ARRA includes the Health Information Technology for Economic and Clinical Health 
(HITECH) Act, which encourages the adoption of interoperable electronic health records 
and the development of a national health information network. The legislation 
appropriates $20 billion to provide financial incentives to use HIT, to fund grants that 
invest in HIT infrastructure, and to support technical assistance for HIT development, 
adoption, and use. Financial incentives include Medicare payments to encourage doctors 
and hospitals to adopt and use interoperable HIT through bonuses; later, penalties such as 
reduced payment updates would be levied for non-use of HIT. 
 
In an evaluation of HITECH prior to its inclusion in ARRA, CBO estimated that 
such an investment would save Medicare and Medicaid $13 billion over the 2010–19 
period and result in adoption rates of 70 percent for hospitals and 90 percent for 
physicians, compared with the projected adoption rates of 45 and 65 percent, 
respectively, without such public investment and incentives. 
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 CBO Option 
In its December 2008 report, CBO evaluated two options for achieving savings through 
HIT: creating incentives in Medicare for HIT adoption and requiring the use of HIT as a 
condition of Medicare participation. The first option would create a bonus-penalty system 
for use of qualifying HIT systems. Physicians who use a qualifying system would receive 
a 2 percent bonus on top of regular office visit fees during the first five years following 
implementation. Physicians who do not use a qualifying system would be assessed a  
5 percent penalty during the second five years following implementation. This bonus-
penalty option achieves an estimated $4 billion in savings over the 10 years following 
implementation and would result in greater adoption of HIT than either bonuses or 
penalties alone. The second option would require that physicians and hospitals adopt and 
use a qualifying HIT system as a condition of participation in Medicare, beginning in 
2015. This requirement would lead to nearly universal adoption of electronic health 
record systems by physicians and hospitals. CBO estimates such rapid spread would 
reduce administrative overhead, unnecessary utilization of services, and adverse events. 
Without any other changes in federal law, this option would achieve $23 billion in 
savings. If policies adjusted payment rate updates for hospitals to reflect the reduced 
administrative costs, this option could achieve $61 billion in savings over 10 years. 
 
Path Option 
The Path options focused on establishing health information network capacity as well as 
promoting the spread and effective use of HIT by physicians and hospitals. The policy 
would require electronic reporting of key health outcomes to qualify for payment updates 
starting in 2015. To provide funding to support development of network capacity and 
assistance for safety net providers and small practices, the policy would levy a 1 percent 
assessment on private insurance premiums and allocate funds equivalent to 1 percent of 
Medicare expenditures. These funds also would be available to assist small practices, 
safety-net providers, and rural areas in implementing effective HIT. The policy focused 
on ensuring capacity to exchange information across sites of care. The benefits of such 
capacity would accrue to all providers and patients. As a public good, such capacity is 
unlikely to develop without direct support and standards for exchange. The funds raised 
through the assessments would target development of information networks as well as 
adoption of HIT within practices. The policy assumed funding would be available 
starting in 2010. 
 
By 2015, five years after support begins, all physicians and hospitals would be 
required to report electronically on key health outcomes or data elements in order to 
receive full payment updates from Medicare, Medicaid, and the new public health 
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 insurance plan offered through the national insurance exchange. This option is estimated 
to increase use of HIT to 96 percent and to achieve a net savings of $64 billion through 
reduced medical errors, administrative costs, and laboratory tests as well as through 
greater workforce productivity. The investment in HIT could increase such capacity from 
an estimated 5 percent in 2010 to 90 percent by 2017. This expanded capacity would 
enable more integrated care and information exchange throughout the health care 
delivery system. With the acceleration of development, adoption, and use of information 
exchange and HIT networks, the investment would result in an additional national 
savings of $117 billion over the decade. In total, the public investment and HIT policies 
could reduce national spending by $180 billion over 10 years compared with projected 
trends, $70 billion of which accrue to the federal government. The federal savings are net 
of the initial investment. 
 
Comparison 
The Path option to provide federal support for providers to implement HIT is similar to 
HITECH in terms of the provisions for increasing adoption of HIT within practices, with 
a similar estimated adoption rate among physicians. The estimates differ primarily in 
their approach to development of network capacity and inclusion of strong incentives for 
physicians and hospitals to report key data electronically. However, the Path option 
requires reporting of key health outcome data electronically and would thus stimulate use 
of systems as well as the development of national data exchange capacity. All physicians 
and hospitals would be required to report such data electronically in order to receive 
payment updates. The Path policy also would provide substantial funding and support for 
establishment of national, state, or regional information network capacity. This capacity 
could support more integrated care and provide a platform for rapid dissemination of the 
latest clinical information, including medication alerts, to providers. CBO estimates focus 
on the potential savings to the federal budget. The Path estimates illustrate the potential 
for national health system savings from accelerating adoption and use of HIT that has the 
capacity to integrate care across settings and support effective information exchange. 
 
Comparative Effectiveness Research 
• ARRA estimate: Not available 
• CBO estimate: ($1 billion federal budget), $8 billion total health system savings 
• Path estimate: $174 billion federal savings, $480 billion total health system savings 
 
Current Policy 
As medical science evolves, better information on the effectiveness and comparative 
effectiveness of available treatment options, medications, and devices is essential to 
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 support decision-making by providers and patients, as well as by payers. Better evidence 
is important both for existing treatment alternatives and for new treatments and 
technology. There is wide variation in practice patterns across the country and within 
regions, with no apparent relationship between higher costs and better health outcomes. 
The wide variation plus uncertainty about the relative benefits of alternative choices 
indicate that better information to inform decisions and effective use of information could 
reduce spending without sacrificing quality. Moreover, studies provide widespread 
evidence of inappropriate or unsafe care as well as failure to provide recommended care. 
Thus, an objective source of clinical information about what is likely to work well for 
particular patients would improve the quality of care. 
 
Approaches that synthesize information about treatments and outcomes also 
would help inform patients about their care options. Investment in generating better 
information for health care decision-making, combined with incentives to encourage 
more effective use of available information, could reduce unnecessary care, increase the 
provision of appropriate care, and improve the management of chronic conditions. 
Information about the relative costs of similarly effective care options could further 
inform decisions—and potentially control costs over time while improving health care 
quality and outcomes. 
 
ARRA Provision 
ARRA provides $1.1 billion to invest in comparative effectiveness research. Of this 
amount, $700 million would support the Agency for Healthcare Research and Quality 
(AHRQ) for comparative effectiveness research, including $400 million for the National 
Institutes of Health (NIH). An additional $400 million is allocated to the HHS Secretary 
to conduct, support, or synthesize comparative effectiveness research and to encourage 
the development and use of infrastructure and systems to generate or obtain outcomes 
data. The provision also establishes an interagency advisory panel to help coordinate and 
support comparative effectiveness research. The panel must report to the president and 
Congress annually but may not mandate coverage, reimbursement, or other policies for 
payers, and the panel’s recommendations may not be construed as mandates or clinical 
guidelines for payment, coverage, or treatment. The budget did not provide an estimate of 
potential savings from this investment. 
 
CBO Option 
Under the CBO option, the federal government would fund research on the comparative 
effectiveness of alternative medical treatments over the next decade. Funding would 
begin at $100 million in 2010, grow to $400 million in 2014, and remain at that level 
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 through 2019. This would generate improved evidence-based information to inform medical 
practice. CBO estimates that the investment would result in a $1 billion increase in 
federal spending, although it would yield $8 billion in reduced national health expenditures. 
 
Path Option 
The Path reforms include the creation of a new Center for Comparative Effectiveness 
Research and Health Care Decision-Making (Center), which would synthesize and 
conduct research on the relative effectiveness of alternative therapies. The Center would 
be a public–private partnership, operating as an independent, quasi-governmental entity. 
To ensure budget independence and provide resources for operations, the policy provides 
for contributions equal to .05 percent of projected Medicare and Medicaid spending from 
the public sector and .05 percent assessment on private insurance premiums. The Center 
would be mandated to produce and disseminate comparative effectiveness information, 
guided by national priorities. The Center also would recommend incentives to inform 
public and private insurance payment and benefit design policies. 
 
In addition, policies included in the Path approach would support the use of 
decision aids designed to inform patients of alternative treatment options, when 
appropriate. The policies would inform decisions made by Medicare, Medicaid, and the 
new public health insurance option regarding patient cost-sharing and relative pricing for 
alternative treatments, medications, and other clinical care. The estimates assume public 
and private insurance plans will incorporate such incentives into benefit designs and 
provide payments to promote effective and appropriate care. Payment and cost-sharing 
provisions would provide financial incentives to avoid high-cost options that are no more 
effective than lower-cost alternatives. Using the assumption that better information would 
be available and put to use, Lewin estimates national savings from 2010–19 to be a 
cumulative $480 billion compared with projected trends, with $174 billion in federal 
savings over the same period. 
 
Comparison 
The ARRA provisions make an initial investment in comparative effectiveness research 
but do not provide ongoing funding or an advisory capacity to inform public or private 
health insurance policy decisions. Under the ARRA provisions, research remains 
decentralized, conducted separately by NIH, AHRQ, and the Secretary of HHS and 
evaluated by an advisory panel. The legislative language decouples the generation of 
information from payment policy. 
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 Under the CBO option, comparative effectiveness research is funded entirely by 
the federal government, whereas Path’s Center receives both public and private funding 
for research and dissemination—an estimated $12 billion investment over 10 years. The 
CBO estimates rely on voluntary use of new information by patients and providers and  
do not assume a mechanism to translate evidence-based information into incentives for 
patients or providers to apply the information. 
 
Under the Path option, research would be centralized in a new, independent 
entity, responsible for generating information and making recommendations for payment 
and cost-sharing policies. In addition, the policy would spread use of decision aids to 
inform patients of the risks and benefits of alternative treatment choices. Both policies 
would accelerate the use of comparative effectiveness information to improve the quality 
of care. In addition, both would reduce the delivery of care that is of little or no benefit as 
well as reduce the delivery of high-cost care when lower-cost alternatives exist. The 
incorporation of new information into payment and cost-sharing policies accounts for a 
great deal of the estimated savings from this option. 
 
High-Cost Area Update 
• OMB Budget or ARRA: Not available 
• CBO estimate: $51 billion federal savings 
• Path estimate: $100 billion federal savings, $177 billion total health system savings 
 
Current Policy 
Medicare spending per enrollee varies widely across geographic areas. For example, 
Medicare spending per enrollee ranged from a high of $14,359 In Miami, Fla., to a low of 
$5,281 in Rapid City, S.D., in 2005. Analysis indicates that variations in practice patterns 
drive such differences in spending, rather than variations in the cost of living or health 
status. Moreover, lower-cost areas often have quality and outcomes that are at least as 
good as or better than in high-cost areas. Because Medicare prices per unit of service are 
predetermined and paid through fee-for-service payments, the program creates incentives 
to provide increasingly more services that drive up costs—especially in geographic areas 
with high ratios of specialized resources to population. High-cost regions of the country 
tend to have relatively few primary care providers and more expensive resources (e.g., 
hospitals, diagnostic facilities, and specialists) than lower-cost geographic regions. 
 
ARRA and OMB Option 
Neither the Administration’s budget request nor the economic stimulus package 
specifically addressed a high-cost area update modification. 
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 CBO Option 
In the CBO option, payment rates in traditional Medicare FFS plans would be reduced for 
areas with relative spending of 10 percent or more above the national average. These 
high-cost areas would see a payment reduction equal to one-half the difference between 
their relative spending, compared with the national average and 110 percent of the 
national average. Payment reductions would be phased in over five years and capped at 
20 percent, and would apply to all payments made on the basis of a fee schedule (e.g., 
payments to physicians, hospitals, and post–acute care providers). CBO estimates that 
this would yield $51 billion in savings to the federal government over the 2010–19 period 
and would reduce beneficiaries’ out-of-pocket costs by an unspecified amount. 
 
Path Option 
To encourage more prudent use of resources in high-cost areas, payment updates for all 
providers each year would be based on total Medicare spending per beneficiary in each area 
relative to the national median, adjusted appropriately for costs beyond hospitals’ control. 
The payment update in each area would be adjusted to reflect the percentage difference 
between Medicare spending per beneficiary in the region and the national median, with 
the full updates being applied for providers in low-cost areas (those with costs below 105 
percent of the median), no updates for providers in areas with very high costs (those with 
costs at or above 125 percent of the median), and reduced updates (according to a sliding 
scale) for other areas with high costs (between 105 percent and 125 percent of the 
median). The update adjustments would be recalculated each year, based on the most 
recent data on Medicare spending per beneficiary, so that areas that improve their costs 
relative to the national median can increase their payment updates over time. 
 
This payment policy would apply to traditional Medicare and the public health 
insurance plan offered through the national connector. Lewin estimates that this would 
yield $100 billion in savings to the federal government over the 2010–19 period and  
$177 billion in reduced national health expenditures over the same period. 
 
Comparison 
The Path and CBO options use similar approaches to reduce the geographic variation in 
Medicare payments per beneficiary by reducing payment updates in high-cost areas. 
However, the Path option is more stringent, reducing the update amount on a sliding scale 
for providers with costs between 105 and 125 percent of the median and eliminating 
updates for providers with costs at or above 125 percent of the median. The CBO option 
reduces the payment rate on a sliding scale for providers with costs above 110 percent of 
the national average but caps the reduction at 20 percent. Additionally, the Path option 
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 would apply not only to Medicare providers but also to providers participating in the 
public health insurance plan offered through the national connector. These differing 
approaches explain the varying estimates of savings to the federal government. 
 
Reduce Subsidies to Hospitals for Treating Uninsured as Coverage Increases 
• OMB estimate: $106 billion federal savings 
• CBO estimate: Not available 
• Path estimate: $9 billion federal savings in 2010, 10-year estimate not available 
 
Current Policy 
Medicare currently offers hospitals a disproportionate share (DSH) payment for treating 
low-income patients. States also receive an annual DSH allotment to cover the costs of 
DSH hospitals that provide care to low-income patients that are not paid for by other payers 
such as Medicare, Medicaid, CHIP, or other health insurance. If health reform achieves 
near-universal health insurance coverage, hospitals will be providing significantly less 
uncompensated care, and the resources currently allotted to DSH payments to hospitals and 
states could be redirected to pay for health reform. 
 
OMB Option 
The Administration’s supplemental financing proposals include an option to establish a 
new mandatory mechanism to better target payments to hospitals for uncompensated care. 
Beginning in 2013, payments would be phased down so that DSH funding in 2019 would 
equal 25 percent of DSH funding in 2013, updated by inflation. This would save an 
estimated $106 billion over the 2010–19 period. 
 
CBO Option 
CBO did not model an option to reduce DSH payments as coverage increases. However, in 
a letter to Senator Conrad, CBO director Doug Elmendorf noted that expanding coverage 
would allow for a reduction in DSH payments and would save resources. 
 
Path Option 
The Path policies include an expansion of coverage and the elimination of federal DSH 
funding beginning in 2010. Lewin estimated the savings from this elimination for 2010 
alone, finding that this would yield $9.4 billion in savings to the federal government. No 
estimate was provided for the 2010–19 period. 
 
Comparison 
There is agreement that as coverage expands, less resources will be needed to reimburse 
hospitals for uncompensated care or for providing care to low-income individuals. The 
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 OMB estimate included the entire 10-year budget window, whereas the Lewin estimate 
was solely for 2010. 
 
Manage Physician Imaging 
• OMB estimate: Not available 
• CBO estimate: $1 billion federal savings for prior authorization, $3 billion federal 
savings for equipment utilization factor increase 
• Path estimate: $23 billion federal savings, $29 billion total health system savings 
 
Current Policy 
Medicare spending on imaging services doubled from 2000 to 2007, making these 
services one of the fastest growing areas of spending in the Medicare program. Not all of 
the increased use of imaging may be appropriate: there is an almost eightfold variation in 
per beneficiary spending on in-office imaging services across the states, and costly 
imaging services may be mispriced under the physician fee schedule, creating financial 
incentives for physicians to provide more imaging. Congressional and executive agencies 
have recommended that in addition to the retrospective controls on payment now in 
place, CMS also begin to use prospective controls. Reducing the rate of growth of 
spending on imaging could yield substantial savings to the Medicare program. 
 
OMB Option 
To provide more accurate payment for physician imaging services, this option would 
allow HHS and CMS to increase the equipment utilization factor for advanced imaging 
such as magnetic resonance imaging and computed tomography machines from 50 
percent to 95 percent. OMB did not provide a specific estimate for this option, but 
included it in a summary category yielding a total of $22 billion in savings to the federal 
government over the 2010–19 period. 
 
CBO Options 
CBO considered two options to better manage physician imaging. The first would require 
physicians to obtain prior authorization for the use of and payment for advanced imaging 
services in Medicare. Radiation benefit managers would decide whether to approve 
payment for a specific imaging service based on criteria formulated from recommended 
guidelines for clinical practice. Medicare would not reimburse services that were not 
approved. CBO estimates that this would yield $1 billion in savings to the federal 
government over the 2010–19 period. 
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 The second option CBO considered would modify the equipment utilization factor 
for advanced imaging in calculating physicians’ fees in Medicare. In determining practice 
expense, CMS would assume imaging equipment is used 95 percent of the time, a 
significant increase from the current assumption of 50 percent. This higher utilization 
factor would spread the cost of the equipment over more units of service, resulting in 
smaller payments per service. Although any changes to the practice expense component 
are budget neutral and savings are redistributed to other areas of the physician fee 
schedule, Congress can specify that this budget neutrality provision does not apply to a 
specific option. CBO estimates that if the budget neutrality provision were waived, this 
would yield $3 billion in savings to the federal government over the 10-year period. 
 
Path Option 
The Path policies included a prior authorization program for Medicare imaging services 
using radiology benefit managers that would achieve an initial reduction in Medicare 
imaging services by 20 percent in 2010 and a 50 percent reduction in the rate of growth 
of these services from the current baseline spending estimates. This policy would also 
apply to the public plan option offered in the new exchange. Lewin estimates that the 
prior authorization program would yield $23 billion in federal savings and $29 billion in 
reduced national health spending over the 2010–19 period. 
 
Comparison 
The equipment utilization options are quite similar in structure and reflect a growing 
consensus that this option may effectively reduce the costs of physician imaging. 
MedPAC proposed a very similar option in its June 2009 report to Congress. The CBO 
and Path prior authorization options are similar but differ in their scope: the CBO option 
would apply to Medicare beneficiaries only, and the Path option would apply to Medicare 
beneficiaries and enrollees in the new public plan. Both estimates reflect an assumption 
that there would be a substantial initial decline in utilization after the policy was 
implemented, but CBO assumes that the rate of growth in utilization and spending would 
quickly return to the current rate, whereas Lewin assumes the rate of growth would be 
reduced by half, accounting for Lewin’s larger estimate of savings. 
 
Reduce Waste, Fraud, and Abuse 
• OMB estimate: Not available 
• CBO estimate: $0.5 billion federal savings 
• Path estimate: Not available 
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 Current Policy 
The Health Care Fraud and Abuse Control program works to reduce fraud and abuse in 
the Medicare and Medicaid programs. Money from this program supports activities in 
various agencies and offices, and funds efforts including audits of providers’ claims for 
payment and evaluation of the Medicare and Medicaid programs to identify improprieties 
and recommend corrective action. Various analyses have found that investing in fraud 
and abuse reduction and prevention activities produces a return on investment ranging 
from 1.75/1 to 13/1. Investing more resources in these activities could produce returns 
that could be used elsewhere in the health care system. 
 
OMB Option 
The Administration suggests increasing the scrutiny of physicians in high-risk areas or 
those that order a high volume of high-risk services through additional prepayment 
review. OMB did not provide a specific estimate for this option, but included it in a 
summary category yielding a total of $22 billion in savings to the federal government 
over the 2010–19 period. 
 
CBO Option 
This option would provide an additional $100 million in appropriated funding for the 
Health Care Fraud and Abuse Control program each year for the 2010–19 period. CBO 
estimates that this investment could yield $0.5 billion in savings to the federal government 
over the 10-year period. Although this would decrease the deficit, it could not be scored 
as a savings due to the rules governing CBO. 
 
Path Option 
The Path policies did not specifically address fraud, waste, and abuse and Lewin did not 
provide a corresponding estimate. 
 
Comparison 
The Administration’s option aligns with the CBO option in that both recognize the return 
on investment available from increasing activities to prevent and reduce fraud, waste,  
and abuse. 
 
Select Population Health Options 
• ARRA estimate: Not available 
• CBO estimate: $205 billion federal revenues 
Note: CBO estimate is for the 2009–18 period 
• Path estimate: $247 billion federal savings, $583 billion total health system savings 
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 Current Policy 
More than a third of all illness is the result of poor diet, lack of exercise, and smoking. 
Population health initiatives such as tobacco, alcohol, and sugar-sweetened beverage taxes 
aim to lower the rate of chronic disease and preventable illness and increase tax revenue. 
 
ARRA Option 
ARRA provides $1 billion for a Prevention and Wellness Fund to be administered by  
the HHS Secretary, including $300 million for the Centers for Disease Control and 
Prevention’s immunization program, $650 million for evidence-based clinical and 
community-level prevention and wellness programs to address chronic disease, and  
$50 million for state activities to reduce health care–associated infections. In addition,  
the Administration’s budget emphasizes the importance of prevention and wellness to 
improve population health as one component of comprehensive health reform, but does 
not specify any additional provisions beyond the funds allocated in ARRA. 
 
CBO Option 
CBO considered three separate “sin” taxes to improve population health. The first option 
would increase the federal excise tax on cigarettes by one dollar per pack beginning in 
2010. The increased revenue from the excise tax would be partially offset by reductions 
in payroll and income taxes. CBO projects that, for each 10 percent increase in the price 
of cigarettes, consumption will fall by 4 percent to 6 percent. The tobacco tax provision is 
estimated to yield $95 billion in federal revenues over the 2009–18 period. 
 
The second option CBO considered was to impose a federal excise tax of $0.03 
per 12 ounces of sugar-sweetened beverage (sugar drink), which would include a variety 
of beverages such as non-diet soft drinks, fruit cocktails, fruit drinks, flavored iced teas, 
and flavored milks. The tax would apply to beverages sweetened with sugar, high-
fructose corn syrup, or similar sweeteners, but not to artificially sweetened soft drinks. 
Revenue from this excise tax would be $50 billion over the 2009–18 period. This 
estimate reflects reductions in consumption and production of soft drinks as well as 
reduced income and payroll tax revenue that would stem from the excise tax. CBO 
acknowledges that this option would have a small but quantifiable effect on average body 
mass index and may reduce federal outlays for health care, but does not incorporate these 
effects into the estimate. 
 
Similarly, CBO considered an increase on the federal excise tax on alcoholic 
beverages using the proof gallon as the measure. The tax rate would be raised to $16.00 
per proof gallon compared with the current $13.50 per proof gallon for spirits, $18.00 per 
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 barrel of beer, and $1.07 per gallon of wine. The standardized, increased excise tax would 
increase revenues by $60 billion over the 2009–18 period. CBO indicates that alcohol 
consumption creates costs for society that are not reflected in the pretax price of alcoholic 
beverages. Reducing these external costs would yield broad social benefits that would 
likely far outweigh the revenues derived from current alcohol excise taxes. However, 
CBO did not include an estimate of the financial ramifications of these potential social 
and health gains. 
 
Path Option 
Path policies include three options targeting prevention and wellness: a tobacco tax, an 
alcohol tax, and an obesity abatement effort. The tobacco tax option would increase the 
federal cigarette tax by two dollars per pack, with taxes on other types of tobacco 
products increased in the same proportion. One percent of these revenues would be used 
to fund smoking cessation programs. Lewin estimates that smoking cessation induced by 
the increased tax could yield a significant reduction in national health spending above the 
increased revenues from the tax through improved population health; the initiative is 
estimated to achieve $79 billion in federal government savings and $215 billion in net 
national savings over the 2010–19 period. 
 
The alcohol tax option would increase the federal excise tax on alcohol from 
$0.05 per 12 ounces of beer to $0.10 per 12 ounces of beer, with a similar proportional 
increase in the taxes on other alcohol products. A portion of revenues from this increase 
would be used to strengthen the Substance Abuse and Mental Health Services 
Administration (SAMHSA) Center for Substance Abuse Prevention’s national alcohol 
and illicit substance abuse prevention programs, as well as to give block grants to states 
for their own control programs. Lewin estimates that the increased excise taxes would 
yield $47 billion in federal revenues over the 2010–19 period. Lewin noted that alcohol 
consumption leads to additional health expenditures and that a tax increase would likely 
lead to decreased consumption, but does not estimate the impact. 
 
The obesity abatement effort in the Path options relies on a tax on sweetened soft 
drinks of $0.01 per 12 ounces. The tax would discourage soft drink consumption and also 
fund state-run obesity abatement programs. Lewin estimated that this tax increase would 
result in declining sales of sweetened soft drinks at a rate of 0.58 percent per year, 
yielding $10 billion in net federal revenues over the 2010–19 period. One percent of 
these revenues would be reinvested in block grants to states for qualifying obesity 
prevention programs. Lewin estimated the potential national savings if such initiatives 
were to achieve a 50 percent reduction in the growth of the share of national health 
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 expenditures attributable to obesity, cutting the rate of increase from 0.40 percent per 
year to 0.20 percent per year. This yields an estimated $323 billion in decreased national 
health expenditures over the 2010–19 period. Overall, Lewin estimates that the Path 
option aimed at reducing rates of obesity and the associated levy on sugar drinks would 
yield $121 billion in federal government savings and $321 billion in total health system 
savings over the 2010–19 period. In addition to the increased revenue through new or 
increased taxes, these three provisions would improve the population’s health and result 
in health system savings far beyond the revenue from the taxes alone. 
 
Comparison 
The funding allocated in ARRA aims to improve population health and reduce health 
spending in the long term, but no estimate of these potential future savings is available. 
The CBO and Path options demonstrate that prevention and wellness measures can 
simultaneously raise revenue and improve population health. Although the CBO and Path 
options addressed the same behaviors (tobacco, alcohol, and sugar drink consumption), 
they used different tax rates and policy approaches (e.g., obesity abatement program vs. 
tax alone) and reached very different conclusions, although they both concluded that the 
select policy options would generate savings. 
 
The main difference between the tobacco estimates is the level of tax increase: the 
CBO option estimates revenues from a one-dollar increase compared with the Path 
option’s two-dollar increase for cigarettes and proportional increases on other tobacco 
products. A second major difference between the two is that the Lewin estimate includes 
net savings in national health spending from reduction in health care utilization due to 
smoking cessation. While CBO acknowledges that smoking cessation is likely at the 
same levels used by Lewin, the CBO estimate does not estimate potential savings. 
 
The most significant difference between the soft drink initiatives is the Lewin 
estimate of the potential if initiatives were to succeed in reducing the rate of increase in 
obesity. CBO estimates examine the increased federal revenue from taxes alone, while the 
Lewin estimate of the Path obesity abatement policy also estimates the potential reduction 
in spending from improved population health. The estimates also rely on different 
amounts of tax increase. Lewin’s revenue estimate also may be lower due to a narrower 
tax; the CBO option applied to all beverages sweetened with sugar and the Path option 
applies only to soft drinks, excluding fruit drinks and other sugar-sweetened beverages. 
 
The Path and CBO policies also differ in terms of the rate of alcohol tax. The 
CBO option estimates an increase in alcoholic beverage excise tax up to a standard 
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 $16.00 per proof gallon across all types of alcohol (an average 92 percent increase in the 
alcohol excise tax), yielding $60 billion in federal tax revenues over 10 years. By 
comparison, the Path option would double the alcoholic beverage excise tax for all types 
of alcohol, yielding $47 billion in federal tax revenues over 10 years. CBO projects that 
the increase in alcohol excise tax would yield increasing revenues each year and Lewin 
projects relatively steady revenues each year after implementation. 
 
CONCLUSION 
The proposed $634 billion health care reserve fund and additional $313 billion in savings 
is a historic step toward comprehensive health reform and more affordable, high-quality 
health care. The proposal signals the Administration’s view of the importance of health 
reform and its willingness to invest in the U.S. health system to achieve meaningful 
change. In particular, the Administration’s budget identifies innovative strategies to 
eliminate waste while improving the quality of care. However, additional policies will be 
needed to finance federal efforts to extend insurance coverage to everyone and achieve a 
high-quality health care system while slowing the growth in health care costs. 
 
Changing the way public and private insurance programs pay for care has the 
potential to improve outcomes and patient experiences while at the same time providing 
strong incentives for more efficient care. Better information systems and population 
health initiatives could accelerate the pace of change, with benefits accruing broadly to 
families, businesses, and public and private insurance programs. The estimates of the 
potential impacts of different policies indicate that there is potential for significant gains. 
As illustrated above, the available estimates differ primarily in terms of the scope of the 
policies and particular elements of the proposals. 
 
As the health care reform debate unfolds, it will be important to keep in mind  
that there are various options for financing the necessary federal investment and 
stimulating change throughout the care system. The challenge will be building consensus 
to move forward and implement policies that have the potential to simultaneously address 
health care access, quality, and costs. Implementing the changes necessary to put the U.S. 
health system on a path to high performance will be difficult and require a significant 
upfront investment. 
 
Yet, without bold initiatives, the nation faces a future in which millions more 
Americans are denied access to needed care and the health care system consumes a 
growing share of national income, without providing adequate value. The Obama 
Administration has begun to make changes by prioritizing health reform and identifying 
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 areas where greater efficiency is possible. Congress now has the challenge and 
opportunity to forge consensus to move forward. National economic recovery and the 
nation’s health and productivity depend on an accessible, high-quality, and efficient 
health care system. 
 
Methodology Note on Path Estimates 
 
Modeling the recommendations of the Commonwealth Fund Commission on a High 
Performance Health System for health system reform required detailed specifications for each 
of the proposed policy approaches. The Path policy specifications were used for illustrative 
purposes. Recognizing that multiple policy variations are feasible for key policy reforms, the 
Commission endorsed the conceptual, strategic approaches rather than the specific policy 
parameters used to model potential effects. The main Path report provides further detail. The 
Lewin Group technical report, The Path to a High Performance U.S. Health System: Technical 
Documentation, is available online at www.Lewin.com. It details the data and parameters used 
to estimate the potential effects of particular policies over 2010–19. 
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 NOTES 
 
1 For details of the Administration’s budget proposal, see sidebars. 
2 Ranges between $1 trillion and $1.7 trillion have been estimated by the Lewin Group, the 
Council of Economic Advisers, CBO, and others. See reference list for sources. 
3 For a description of the Path framework and policies, see The Commonwealth Fund 
Commission on a High Performance Health System, February 2009. The Lewin Group (Lewin) 
provided estimates of costs and savings for the Path options. A technical appendix details 
assumptions and policy specifications. The Congressional Budget Office (CBO) released a two-
volume report on budget options for achieving federal savings in December 2008, with the first 
volume dedicated to health care. The Office of Management and Budget (OMB) estimated the 
impact of the provisions laid out in the President’s FY2010 budget and in the ARRA stimulus 
legislation. In addition, the White House released OMB estimates for $313 billion in additional 
savings in June 2009. See reference list for sources. 
4 All estimates of future spending include a degree of uncertainty, particularly those 
expressed as point estimates rather than a range. For more information about the evidence used to 
support assumptions and estimates, see CBO Budget Options, Volume 1, and Lewin technical 
appendix. 
5 See Appendix for technical notes on Lewin estimates. 
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 APPENDIX. TECHNICAL NOTES ON LEWIN GROUP ESTIMATES 
OF SAVINGS FROM PATH POLICY OPTIONS 
 
Expanded Population and Increased Federal Baseline Spending 
Many of the policies evaluated by the Lewin Group would apply to an expanded 
population through a public health insurance option for those under age 65. This 
expansion would give the proposed policies greater impact and produce increased 
savings. To account for the higher federal baseline spending due to the expanded 
population, Lewin estimated the increases to the baseline through subsidies, an expansion 
of Medicaid, and other investments. For more detail, see the Lewin technical appendix. 
Where possible, the description of the Lewin estimate distinguishes between federal 
savings through Medicare versus through a new public health insurance option for the 
under-65 population. 
 
Wage Effects and Increased Productivity 
Lewin estimates that the comprehensive set of Path policies implemented together would 
save households over $2.3 billion over the 2010–19 period. However, estimates of the 
impact of the Path policies do not adjust for wage effects (i.e., higher tax income due to 
households’ increased income and decreased health spending) or for productivity effects 
from improved health or increased workforce participation. 
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